All Updates

All Updates

icon
Filter
Partnerships
Insilico Medicine and invoX Pharma collaborate to enhance oncology research and development through AI
AI Drug Discovery
Apr 23, 2024
This week:
Funding
MeliBio receives strategic investment from Future Food Fund
Alternative Ingredients
Yesterday
Product updates
Catchfree launches microalgae-based shrimp alternative
Plant-based Meat
Yesterday
Product updates
AQUA Cultured Foods introduces fermentation-based raw tuna alternative
Plant-based Meat
Yesterday
Management news
SDI Element Logic rebrands as Element Logic
Logistics Tech
Yesterday
Geographic expansion
Wayve opens office and commences testing of automated driving features in US
Auto Tech
Yesterday
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
AI Drug Discovery

AI Drug Discovery

Apr 23, 2024

Insilico Medicine and invoX Pharma collaborate to enhance oncology research and development through AI

Partnerships

  • AI-driven drug development company Insilico Medicine and invoX Pharma, a research-driven global biopharmaceutical company, have teamed up to improve R&D in oncology with the help of AI, computational services, and data science. The terms and financial details of the partnership have not been disclosed.

  • The partnership will leverage Insilico’s proprietary AI platform, PandaOmics, with invoX’s drug discovery, development, and data science capabilities to identify potential uses for drugs in development within invoX’s current pipeline. This collaboration also plans to train large AI models to be used in multiple projects, initiating new uses throughout the term of the partnership.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.